Register through Sept. 17 to receive the lowest rates for Advancing Gene + Cell Therapies for Cancer.
Browse and view ASGCT's cancer-focused content on-demand. This resource is made available exclusively for ASGCT members.
ASGCT membership unlocks incredible discounts and on-demand access to a rich archive documenting the history of cell and gene therapy. Take the next step in your career by becoming an ASGCT member.
Join
January 21, 2022 During this two-hour café, Dr. Stephen Gottschalk gives a short introduction about gene therapy and continues into a structured discussion about CAR T-cell therapy. 🔒
October 20, 2023 Discover the latest insights into how pathogen recognition and innate immune signaling affect non-viral nucleic acid delivery. 🔒
April 23, 2024 This webinar dives into cutting-edge strategies in target discovery and biomarkers. 🔒
October 5, 2024 Speakers during this session review the current state of CAR T-cell therapies. They also provide updates on how CRISPR-based genome editing technologies are being applied to further understanding of T-cell function and to create novel T-cell products for patients. 🔒
August 1, 2023 This program aims to transcend the basics of cell therapy and CAR T cells and digs deeper into gene engineering and the intersection of gene and cell therapy in this space. 🔒
August 2, 2023 This program aims to transcend the basics of cell therapy and CAR T cells and digs deeper into gene engineering and the intersection of gene and cell therapy in this space. 🔒
June 10, 2022 Dr. Cerullo discusses tumor-infiltrating lymphocytes (TILs), an experimental cell therapy being developed for treating solid tumors, and tumor-specific antigens (TSAs), which can help the body make an immune response against cancer cells. 🔒
September 23-24, 2024 | Washington, D.C.
© 2000-2024 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico